Cel Sci (CVM) Gains from Investment Securities (2019 - 2020)
Cel Sci's Gains from Investment Securities came in at $3.91 million for fiscal Q4 2020 (quarter ended Sep 30, 2020), down 4.0% from $4.08 million a year earlier.
Powered by 
Analysis
Cel Sci (CVM) Gains from Investment Securities (2019 - 2020) Analysis & Trends
For FY2020 (ended Sep 30, 2020), Cel Sci's Gains from Investment Securities was $349,078, down 54.1% from FY2019.
- Going back by fiscal year, Gains from Investment Securities was $760,603 in FY2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Cel Sci | 4.09 Mn | -21.56 Mn | - |
API Access
Cel Sci Gains from Investment Securities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-investment-securities", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();